mOrange Antibody

What is mOrange fluorescent protein and why are antibodies against it important in research?

mOrange is a ~27 kDa monomeric fluorescent protein derived from the Discosoma coral family. It represents an engineered derivative of red fluorescent protein (RFP) with optimal excitation at 548 nm and maximum emission at 562 nm . Antibodies against mOrange are critical research tools that allow scientists to:

• Detect and visualize mOrange-tagged proteins in cells and tissues

• Study protein localization and dynamics beyond direct fluorescence visualization

• Perform biochemical assays on mOrange-fusion proteins

• Enable multi-dimensional analysis combining fluorescence microscopy with immunological methods

Unlike direct fluorescence observation, antibodies against mOrange enable detection through non-fluorescent methods (like Western blotting) and can amplify signals through secondary antibody systems, providing greater flexibility in experimental design .

What types of mOrange antibodies are available and how do they differ?

Several types of mOrange antibodies are available for research applications:

The choice between these antibodies depends on the specific application, with polyclonal antibodies offering broader epitope recognition and potentially higher sensitivity, while monoclonals provide greater specificity and reproducibility .

What are the primary applications for mOrange antibodies in molecular biology research?

mOrange antibodies support various research applications:

• Western Blotting: Detection of mOrange-tagged proteins in cell/tissue lysates, typically revealing a ~27 kDa band plus the molecular weight of the fused protein

• Immunofluorescence: Visualization of subcellular localization of mOrange-tagged proteins, often with secondary detection systems

• Immunohistochemistry: Detection in both frozen and paraffin-embedded tissue sections

• Immunoprecipitation: Isolation of mOrange-tagged protein complexes

• Immunoelectron Microscopy: Ultrastructural localization studies

• ELISA: Quantitative detection of mOrange-tagged proteins

These applications collectively enable comprehensive analysis of protein expression, localization, and interactions in diverse biological contexts.

How should researchers design controls when using mOrange antibodies in immunoassays?

Proper control design is essential for experiments involving mOrange antibodies:

Positive Controls:

• Lysates from cells transfected with known mOrange-expressing constructs

• Purified recombinant mOrange protein for standard curves in quantitative assays

• Side-by-side comparison with direct fluorescence visualization where possible

Negative Controls:

• Untransfected cells processed identically to experimental samples

• Cells expressing other fluorescent proteins (GFP, etc.) to confirm specificity

• Primary antibody omission controls to assess secondary antibody specificity

• Isotype controls matching the mOrange antibody class and species

For immunoblotting specifically, many researchers confirm the ~27 kDa band corresponding to mOrange alone or the higher molecular weight band representing the fusion protein . For fluorescence-based detection, spectral overlap must be considered when designing multiplexed experiments .

What are the optimal working dilutions and conditions for different applications of mOrange antibodies?

Optimal working conditions vary by application and specific antibody:

Western Blotting:

• Polyclonal antibodies: 1:500-1:5,000

• Monoclonal antibodies: 1:1,000-1:5,000

• Blocking recommendation: 5% non-fat milk or BSA in TBST

• Incubation: Typically overnight at 4°C or 1-2 hours at room temperature

Immunofluorescence:

• Typical dilution range: 1:50-1:500

• Fixation: 4% paraformaldehyde preserves both direct fluorescence and antibody epitopes

• Permeabilization: 0.1-0.5% Triton X-100 or 0.1% saponin

• Background reduction: Pre-incubation with serum matching secondary antibody host

Immunohistochemistry:

• Frozen sections: 1:50-1:500

• Paraffin sections: 1:50-1:500 (may require antigen retrieval)

• Antigen retrieval: Citrate buffer (pH 6.0) or EDTA buffer (pH 9.0)

Immunoelectron Microscopy:

• Typical dilution: 1:50-1:500

• Fixation: Glutaraldehyde/paraformaldehyde mixture

• Detection: Gold-conjugated secondary antibodies of various sizes

Researchers should always perform titration experiments to determine optimal conditions for their specific experimental system and antibody lot .

How do storage conditions affect mOrange antibody performance and what is the optimal storage protocol?

Proper storage is critical for maintaining antibody performance:

Short-term Storage (up to one month):

• Temperature: 2-8°C (refrigeration)

• Buffer conditions: Original shipping buffer (typically PBS with preservatives)

• Avoid repeated freeze-thaw cycles

Long-term Storage:

• Temperature: -20°C

• Aliquoting: Divide into single-use aliquots to prevent freeze-thaw damage

• Preservatives: Most commercial preparations contain glycerol (20-50%) and sodium azide (0.05%)

Working Dilutions:

• Typically stable for up to 12 hours at working dilution

• Discard diluted antibody if not used within recommended time frame

Performance Indicators of Degradation:

• Increased background in immunoassays

• Decreased signal-to-noise ratio

• Precipitation or visible particles in the antibody solution

• Loss of specificity in Western blot applications

Researchers should note that sodium azide, a common preservative in antibody preparations, is a potent inhibitor of HRP (horseradish peroxidase), so thorough washing is essential before using HRP-conjugated secondary antibodies .

How can researchers distinguish between direct mOrange fluorescence and antibody-based detection in imaging applications?

Distinguishing between direct fluorescence and antibody-mediated signal requires careful experimental design:

Methodological Approaches:

• Spectral Separation:

  • Direct mOrange fluorescence: Excitation ~548 nm, emission ~562 nm

  • Secondary antibody fluorophores: Choose those spectrally distinct from mOrange (e.g., far-red or blue fluorophores)

• Fixation-Dependent Analysis:

  • Native mOrange fluorescence can be quenched by certain fixatives

  • Perform imaging before and after fixation/antibody staining

• Photobleaching Strategy:

  • Selectively photobleach direct mOrange signal

  • Remaining antibody-detected signal reveals differences

• Parallel Sample Approach:

  • Process identical samples for direct fluorescence and antibody detection separately

  • Compare localization patterns and signal intensities

This distinction is particularly important when studying protein dynamics or when quantifying absolute protein levels, as antibody detection may amplify weak signals that might be below direct fluorescence detection threshold .

What are the most common causes of non-specific binding with mOrange antibodies and how can they be mitigated?

Non-specific binding presents significant challenges when using mOrange antibodies:

For polyclonal goat anti-mOrange antibodies specifically, some researchers report cross-reactivity with other red fluorescent proteins. This can be advantageous for detecting multiple RFPs but may require additional controls when specificity to mOrange alone is required .

How can researchers optimize dual staining protocols that involve both mOrange direct fluorescence and immunolabeling with other antibodies?

Optimizing dual staining protocols requires careful consideration of multiple factors:

Protocol Optimization Steps:

• Fixation Selection:

  • 4% paraformaldehyde (10-15 minutes) typically preserves both mOrange fluorescence and epitopes for immunolabeling

  • Avoid methanol fixation which can quench fluorescent proteins

• Order of Operations:

  • Acquire direct mOrange fluorescence images before immunolabeling when possible

  • If sequential imaging isn't possible, select fixation methods that robustly preserve fluorescence

• Fluorophore Selection:

  • For secondary antibodies, choose fluorophores with minimal spectral overlap with mOrange

  • Recommended combinations:

    • mOrange (direct) + Alexa Fluor 405 or 647 (immunolabeling)

    • mOrange (direct) + Cy5 or Cy7 (immunolabeling)

• Signal Preservation:

  • Use antifade mountants containing reducing agents to minimize photobleaching

  • Consider oxygen-scavenging systems for extended imaging sessions

• Multiplexing Strategy:

  • If detecting the mOrange-tagged protein and other targets:

    • First option: Direct mOrange fluorescence + antibody to second target

    • Second option: Anti-mOrange antibody + antibody to second target (if mOrange signal is too weak)

This integrated approach enables researchers to simultaneously visualize mOrange-tagged proteins via direct fluorescence while detecting other cellular components via immunolabeling .

What strategies can address weak or absent signals when using mOrange antibodies in Western blotting?

When encountering weak or absent signals with mOrange antibodies in Western blotting:

Systematic Troubleshooting Approach:

• Sample Preparation Optimization:

  • Verify expression of mOrange fusion protein (check direct fluorescence if possible)

  • Use fresher lysates (proteolytic degradation may occur during storage)

  • Include protease inhibitors during lysis

  • Try different lysis buffers (RIPA vs. NP-40 vs. Triton X-100)

• Transfer Efficiency Assessment:

  • Use Ponceau S staining to confirm proper protein transfer

  • Consider extended transfer times for larger fusion proteins

  • Optimize methanol concentration in transfer buffer based on fusion protein size

• Detection Enhancement:

  • Increase antibody concentration (try 1:500 instead of 1:5000)

  • Extend primary antibody incubation (overnight at 4°C)

  • Use more sensitive detection reagents (ECL Plus vs. standard ECL)

  • Consider signal amplification systems (biotin-streptavidin)

• Epitope Accessibility Improvement:

  • Try different gel percentages to optimize protein separation

  • Test reducing vs. non-reducing conditions

  • For larger fusion proteins, ensure complete denaturation (increase SDS concentration)

• Antibody Selection:

  • Try alternative clones if available

  • Consider switching from monoclonal to polyclonal antibodies for multiple epitope recognition

These strategies collectively address the most common causes of detection failure in Western blot applications using mOrange antibodies .

How can researchers effectively use mOrange antibodies in multimodal imaging approaches that combine fluorescence microscopy with electron microscopy?

Multimodal imaging combining fluorescence and electron microscopy (EM) represents an advanced application of mOrange antibodies:

Methodological Framework:

• Correlative Light and Electron Microscopy (CLEM) Approach:

  • Begin with live-cell imaging to capture dynamic processes using direct mOrange fluorescence

  • Fix samples using EM-compatible fixatives (2-4% paraformaldehyde + 0.1-0.5% glutaraldehyde)

  • Document fluorescence patterns post-fixation

  • Process for EM using specialized protocols that preserve fluorescence

• ImmunoEM Optimization for mOrange Detection:

  • Pre-embedding labeling: Apply anti-mOrange antibodies before EM processing

    • Dilution range: 1:50-1:500

    • Secondary antibody: Gold-conjugated (typically 5-15nm particles)

  • Post-embedding labeling: Apply antibodies to ultrathin sections

    • Requires specialized resins that preserve antigenicity

    • Often yields lower sensitivity but better ultrastructural preservation

• Integrated Workflows:

  • GridStick approach: Image samples on specialized EM grids that allow fluorescence imaging

  • Fiducial markers: Use multimodal reference points visible in both imaging modalities

  • Software registration: Align fluorescence and EM images using computational tools

This multimodal approach enables precise correlation between protein localization (fluorescence) and ultrastructural context (EM), offering unprecedented insights into protein function within cellular architecture .

What considerations are important when using mOrange antibodies for quantitative analysis across different experimental platforms?

Quantitative analysis using mOrange antibodies requires standardization across platforms:

Key Standardization Elements:

• Absolute Quantification Strategy:

  • Create standard curves using purified recombinant mOrange protein

  • Establish linear detection ranges for each platform (Western blot, ELISA, fluorescence)

  • Account for differences in antibody affinity between native and denatured mOrange

• Cross-Platform Normalization:

  • Use identical reference standards across all platforms

  • Implement parallel technical controls (same lysates/samples) across methods

  • Calculate conversion factors between different detection systems

• Signal Calibration Approaches:

  • For microscopy: Include calibration beads with defined fluorescence intensities

  • For Western blotting: Use gradient loading of standards on each blot

  • For flow cytometry: Apply quantitative beads with defined antibody binding capacity

• Statistical Considerations:

  • Determine appropriate technical and biological replication requirements

  • Establish variance components for each method

  • Apply method-appropriate statistical tests (different platforms have different error distributions)

• Validation Strategy:

  • Cross-validate findings using orthogonal methods

  • Confirm key results with alternative antibody clones

  • Consider absolute quantification methods (e.g., mass spectrometry) for critical measurements

These considerations ensure that quantitative data derived from mOrange antibodies are robust, reproducible, and comparable across experimental platforms and between research groups .

How do the binding kinetics and affinity characteristics of different mOrange antibodies impact experimental design and data interpretation?

Understanding antibody binding kinetics is essential for advanced experimental design:

Binding Characteristics and Implications:

This advanced understanding of antibody kinetics enables researchers to select appropriate antibodies for their specific experimental requirements and interpret data with greater accuracy .

What emerging applications are being developed for mOrange antibodies in advanced imaging and multi-omics research?

mOrange antibodies are finding applications in cutting-edge research techniques:

Emerging Research Applications:

• Super-Resolution Microscopy Integration:

  • STORM/PALM: Using mOrange direct fluorescence with antibody-based fiducial markers

  • SIM: Combining mOrange fusion proteins with antibody-detected reference structures

  • Expansion microscopy: Using anti-mOrange antibodies for protein anchoring during expansion

• Spatial Transcriptomics and Proteomics:

  • In situ detection of mOrange-tagged proteins alongside RNA transcripts

  • Spatial encoding of cellular locations using mOrange fusion proteins

  • Antibody-based signal amplification for low-abundance targets in tissue sections

• Single-Cell Multi-Omics Applications:

  • Protein epitope tagging with mOrange for integrated single-cell proteomics/transcriptomics

  • Flow cytometry sorting based on mOrange fusion proteins followed by single-cell sequencing

  • Development of split-mOrange systems with antibody-based reconstitution detection

• Intravital Imaging Advancements:

  • Tissue clearing protocols compatible with mOrange fluorescence and antibody detection

  • Whole-animal imaging using mOrange direct fluorescence followed by section-specific antibody validation

  • Long-term in vivo imaging with post-experiment antibody validation of expression patterns

• Biosensor Development:

  • mOrange fusion proteins as biosensors with antibody-based endpoint validation

  • Conformational antibodies that detect specific states of mOrange fusion proteins

  • Integration with microfluidic platforms for automated analysis

These emerging applications demonstrate the continuing evolution of mOrange antibodies from simple detection reagents to sophisticated tools in the modern multi-omics research landscape .

How do mOrange antibodies compare to other fluorescent protein antibodies in terms of specificity, sensitivity, and research applications?

Comparative analysis of fluorescent protein antibodies provides important context for researchers:

Comparative Performance Analysis:

Key Comparative Insights:

• Cross-Recognition Patterns:

  • Multi-red 5F8 antibody recognizes multiple red fluorescent proteins

  • Most anti-mOrange antibodies don't cross-react with GFP family proteins

  • This selectivity enables multiplex experimental designs

• Application-Specific Performance:

  • Western blotting: mOrange antibodies typically detect bands at ~27 kDa, similar to other FP antibodies

  • Immunofluorescence: Secondary detection of mOrange offers signal amplification over direct fluorescence

  • Immunoprecipitation: mOrange antibodies perform similarly to other FP antibodies

• Advanced Application Advantages:

  • The spectral properties of mOrange (548/562 nm) provide better separation from cellular autofluorescence than GFP

  • mOrange antibodies enable detection in fixed tissues where direct fluorescence may be compromised

  • The 27 kDa size of mOrange is similar to other FPs, facilitating comparable fusion protein design

This comparative context helps researchers select the most appropriate fluorescent protein and antibody combination for their specific research requirements .

How has the development of antibodies against fluorescent proteins like mOrange contributed to broader advances in molecular biology research?

The development of antibodies against fluorescent proteins has had far-reaching impacts:

Historical and Conceptual Impact:

• Methodological Evolution:

  • Early fluorescent protein research relied solely on direct fluorescence

  • Introduction of antibodies enabled:

    • Detection in fixed/processed samples where fluorescence is lost

    • Amplification of weak signals through secondary detection systems

    • Correlation between fluorescence microscopy and non-fluorescent techniques (EM, biochemistry)

• Technical Innovations Sparked:

  • Correlative light and electron microscopy (CLEM) protocols

  • Multi-modal imaging approaches

  • Integrated proteomics workflows with fluorescent protein tags

  • Enhanced quantification methods across platforms

• Research Field Expansions:

  • Enabled longitudinal studies combining live imaging with endpoint biochemical analysis

  • Facilitated integration of functional imaging with structural biology

  • Supported development of high-throughput screening platforms using fluorescent protein readouts

• Conceptual Advances:

  • Bridge between imaging and biochemical/molecular techniques

  • Validation strategies for fluorescent protein localization

  • Development of antibody-based biosensors that detect specific conformational states

These contributions collectively demonstrate how technical tools like mOrange antibodies drive broader scientific advances by connecting previously separate methodological domains .

How are mOrange antibodies being integrated with emerging technologies like deep learning for automated image analysis?

Integration of mOrange antibodies with deep learning represents an active research frontier:

Current Integration Approaches:

• Automated Segmentation and Quantification:

  • Deep learning models trained to distinguish:

    • Direct mOrange fluorescence vs. antibody-based detection

    • Specific subcellular patterns of mOrange fusion proteins

    • Colocalization of mOrange-tagged proteins with other cellular structures

  • Enables high-throughput analysis of complex localization patterns

• Multi-Channel Image Integration:

  • Neural networks that correlate:

    • Live-cell mOrange fluorescence dynamics

    • Fixed-cell antibody-based detection

    • Additional molecular markers in the same cells

  • Creates integrated datasets spanning multiple imaging modalities

• Quantitative Phenotypic Analysis:

  • Machine learning models that:

    • Classify cellular phenotypes based on mOrange-tagged protein distributions

    • Detect subtle changes in localization patterns following perturbations

    • Extract quantitative features from image data for systems biology approaches

• Future Development Trajectories:

  • Transfer learning approaches using pre-trained models for faster adoption

  • Integration with single-cell multi-omics data for comprehensive phenotyping

  • Automated experimental design optimization using reinforcement learning

These emerging approaches are transforming how researchers analyze and interpret data from experiments utilizing mOrange antibodies, enabling more comprehensive and unbiased assessment of complex biological systems .

What are the current limitations in mOrange antibody technology and what developments might address these challenges?

Current limitations and potential future developments in mOrange antibody technology:

Limitation-Solution Framework:

Future Technology Directions:

• Computationally Designed Antibodies:

  • In silico antibody design for optimal mOrange epitope recognition

  • Structure-based engineering of higher affinity variants

  • Development of application-specific antibody variants

• Integrated Detection Systems:

  • Proximity-based detection combining direct fluorescence with antibody recognition

  • Bifunctional antibodies that simultaneously detect mOrange and amplify signals

  • Modular systems allowing flexible detection strategies

• Emerging Affinity Reagents:

  • Nanobody and single-domain antibody alternatives to conventional antibodies

  • Aptamer-based detection of mOrange protein

  • Engineered protein scaffolds with tailored binding properties

These developments will likely address current limitations and expand the utility of mOrange in complex experimental systems .

How might advances in antibody engineering and deep learning approaches transform the development and application of next-generation mOrange antibodies?

The intersection of antibody engineering and deep learning is poised to transform mOrange antibody technology:

Transformative Technology Convergence:

• AI-Driven Antibody Design:

  • Recent advances demonstrate computational design of antibodies with atomic-level precision

  • This approach could generate:

    • mOrange antibodies with unprecedented specificity

    • Application-optimized variants for specific experimental conditions

    • Antibodies that distinguish between highly similar fluorescent protein variants

• Novel Epitope Targeting Strategies:

  • Machine learning models trained on antibody-epitope interaction data

  • Potential to:

    • Identify novel epitopes unique to mOrange

    • Design antibodies targeting conformational states of mOrange fusion proteins

    • Create antibodies that report on protein interactions or modifications

• Integrated Development Pipeline:

  • Combined deep learning and experimental approaches

  • Workflow components:

    • In silico epitope prediction and antibody design

    • High-throughput screening of candidate antibodies

    • Automated performance optimization across applications

    • Feedback loops integrating experimental outcomes into design algorithms

• Broader Research Impact:

  • Democratization of custom antibody design

  • Rapid development of application-specific reagents

  • Enhanced reproducibility through computationally optimized reagents

  • Integration with other emerging technologies (spatial transcriptomics, single-cell proteomics)

These convergent technologies are likely to produce next-generation mOrange antibodies with substantially improved performance characteristics, enabling new categories of experimental approaches and more robust, reproducible research outcomes .